![Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram](https://www.researchgate.net/publication/306551418/figure/fig3/AS:567236567855104@1512251144196/Progression-free-survival-PFS-A-and-overall-survival-OS-B-based-on-disease-free.png)
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
![Comparison of disease-free survival (A) and overall survival (B) among... | Download Scientific Diagram Comparison of disease-free survival (A) and overall survival (B) among... | Download Scientific Diagram](https://www.researchgate.net/publication/331693832/figure/fig2/AS:865091390017536@1583265268233/Comparison-of-disease-free-survival-A-and-overall-survival-B-among-HCC-ICC-and.png)
Comparison of disease-free survival (A) and overall survival (B) among... | Download Scientific Diagram
![Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804919307488-gr1.jpg)
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect
![Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology](https://www.thelancet.com/cms/attachment/618e2e54-f852-4d2c-b869-631693d2c1b8/gr1_lrg.jpg)
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
![Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive](https://archive.cancerworld.net/wp-content/uploads/2015/10/Correlation-by-itself-does-not-imply-surrogacy.jpg)
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and.png)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40271-021-00552-w/MediaObjects/40271_2021_552_Fig2_HTML.png)
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
![The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival | SpringerLink The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-019-07481-x/MediaObjects/10434_2019_7481_Fig1_HTML.png)
The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival | SpringerLink
![Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive](https://archive.cancerworld.net/wp-content/uploads/2015/10/RCT-of-Letrozole-in-Post-menopausal-breast-cancer.jpg)
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
![JPM | Free Full-Text | Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival JPM | Free Full-Text | Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival](https://www.mdpi.com/jpm/jpm-10-00219/article_deploy/html/images/jpm-10-00219-g001.png)
JPM | Free Full-Text | Impact of Tumor LINE-1 Methylation Level and Neoadjuvant Treatment and Its Association with Colorectal Cancer Survival
![Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram](https://www.researchgate.net/publication/273956724/figure/fig2/AS:282745193418754@1444423115791/Comparison-of-disease-free-survival-DFS-and-overall-survival-OS-according-to-the.png)
Comparison of disease-free survival (DFS) and overall survival (OS)... | Download Scientific Diagram
![VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine](https://www.2minutemedicine.com/wp-content/uploads/2019/07/2MM_VA_6.1.2019_2.jpg)
VisualAbstract: Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer | 2 Minute Medicine
![Comparison Overall survival and Disease free survival graph between two... | Download Scientific Diagram Comparison Overall survival and Disease free survival graph between two... | Download Scientific Diagram](https://www.researchgate.net/publication/349735701/figure/fig3/AS:1000346163879938@1615512519832/Comparison-Overall-survival-and-Disease-free-survival-graph-between-two-groups-A-The.png)
Comparison Overall survival and Disease free survival graph between two... | Download Scientific Diagram
![図3 Overall and disease-free survival curves of patients with initially unresectable disease who underwent resection after downsizing chemotherapy. 図3 Overall and disease-free survival curves of patients with initially unresectable disease who underwent resection after downsizing chemotherapy.](https://www.gi-cancer.net/gi/gi-pedia/vol04/img/z03.jpg)
図3 Overall and disease-free survival curves of patients with initially unresectable disease who underwent resection after downsizing chemotherapy.
![Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2016.83/MediaObjects/41416_2016_Article_BFbjc201683_Fig2_HTML.jpg)
Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer
![Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic](https://d3i71xaburhd42.cloudfront.net/2aa8254fae649d2ab35d92abb79d94fa9d17f39e/4-Figure2-1.png)
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
![Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India](https://f6publishing.blob.core.windows.net/86338a8e-a170-4c94-aa06-3b0be1980f14/WJG-27-7813-g002.png)